Spaltudaq's Series B Round

Spaltudaq raised a round of funding on March 21, 2007.

Spaltudaq Corporation, a privately-held biotechnology company based in Seattle, is focused on developing therapeutic antibodies for the treatment of inflammation, infectious disease and cancer. Our te…

Articles about Spaltudaq's Series B Round: